Selective potentiation of insulin-mediated glucose disposal in normal dogs by the sulfonylurea glipizide

W. S. Putnam, Dana Andersen, R. S. Jones, H. E. Lebovitz

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Investigative data have suggested that the extrapancreatic actions of the sulfonylureas may be paramount in their chronic antidiabetic action. The present study examines the effects of chronic sulfonylurea treatment on in vivo insulin action. Peripheral insulin levels, hepatic glucose production (Ra), and overall glucose disposal (Rd) were studied in 6 awake, normal dogs given both 0.5 and 1.0 mU/kg per min pork insulin for 2.5 h. This produces stable hyperinsulinemia from 15 to 150 min. Fasting euglycemia was held constant by the glucose clamp technique and averaged 99% basal glucose in all studies. Ra and Rd were determined from infusion of [3-3H]glucose, begun 90 min prior to insulin infusion. 10 mg of the sulfonylurea, glipizide, was given daily to the test animals for the 10 to 20 d following appropriate control studies, then was withheld for 24 h, and the dogs were restudied. Glipizide treatment did not significantly alter basal glucose turnover, Ra, mean glucose values, or mean insulin levels as determined by radioimmunoassay. Increase in Rd above basal glucose turnover in response to insulin (ΔRd) was significantly (P <0.05) increased by glipizide treatment at both insulin dosage levels (paired analysis). At 1.0 mU/kg per min insulin, ΔRd rose from 2.6 mg/kg per min before glipizide to 6.5 mg/kg per min after glipizide treatment. At 0.5 mU/kg per min insulin, ΔRd went from 1.1 mg/kg per min before glipizide to 2.2 mg/kg per min after glipizide treatment. Glipizide treatment doubled the effects of insulin on Rd, while showing no significant effect upon insulin suppression of Ra. We conclude that a significant extrapancreatic chronic action of glipizide lies in its ability to selectively potentiate Rd.

Original languageEnglish (US)
Pages (from-to)1016-1023
Number of pages8
JournalJournal of Clinical Investigation
Volume67
Issue number4
StatePublished - 1981
Externally publishedYes

Fingerprint

Glipizide
Dogs
Insulin
Glucose
Aptitude
Glucose Clamp Technique
Hyperinsulinism
Hypoglycemic Agents
Radioimmunoassay
Fasting

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Selective potentiation of insulin-mediated glucose disposal in normal dogs by the sulfonylurea glipizide. / Putnam, W. S.; Andersen, Dana; Jones, R. S.; Lebovitz, H. E.

In: Journal of Clinical Investigation, Vol. 67, No. 4, 1981, p. 1016-1023.

Research output: Contribution to journalArticle

@article{cae24851d9ed49f38b212c0a93416459,
title = "Selective potentiation of insulin-mediated glucose disposal in normal dogs by the sulfonylurea glipizide",
abstract = "Investigative data have suggested that the extrapancreatic actions of the sulfonylureas may be paramount in their chronic antidiabetic action. The present study examines the effects of chronic sulfonylurea treatment on in vivo insulin action. Peripheral insulin levels, hepatic glucose production (Ra), and overall glucose disposal (Rd) were studied in 6 awake, normal dogs given both 0.5 and 1.0 mU/kg per min pork insulin for 2.5 h. This produces stable hyperinsulinemia from 15 to 150 min. Fasting euglycemia was held constant by the glucose clamp technique and averaged 99{\%} basal glucose in all studies. Ra and Rd were determined from infusion of [3-3H]glucose, begun 90 min prior to insulin infusion. 10 mg of the sulfonylurea, glipizide, was given daily to the test animals for the 10 to 20 d following appropriate control studies, then was withheld for 24 h, and the dogs were restudied. Glipizide treatment did not significantly alter basal glucose turnover, Ra, mean glucose values, or mean insulin levels as determined by radioimmunoassay. Increase in Rd above basal glucose turnover in response to insulin (ΔRd) was significantly (P <0.05) increased by glipizide treatment at both insulin dosage levels (paired analysis). At 1.0 mU/kg per min insulin, ΔRd rose from 2.6 mg/kg per min before glipizide to 6.5 mg/kg per min after glipizide treatment. At 0.5 mU/kg per min insulin, ΔRd went from 1.1 mg/kg per min before glipizide to 2.2 mg/kg per min after glipizide treatment. Glipizide treatment doubled the effects of insulin on Rd, while showing no significant effect upon insulin suppression of Ra. We conclude that a significant extrapancreatic chronic action of glipizide lies in its ability to selectively potentiate Rd.",
author = "Putnam, {W. S.} and Dana Andersen and Jones, {R. S.} and Lebovitz, {H. E.}",
year = "1981",
language = "English (US)",
volume = "67",
pages = "1016--1023",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "4",

}

TY - JOUR

T1 - Selective potentiation of insulin-mediated glucose disposal in normal dogs by the sulfonylurea glipizide

AU - Putnam, W. S.

AU - Andersen, Dana

AU - Jones, R. S.

AU - Lebovitz, H. E.

PY - 1981

Y1 - 1981

N2 - Investigative data have suggested that the extrapancreatic actions of the sulfonylureas may be paramount in their chronic antidiabetic action. The present study examines the effects of chronic sulfonylurea treatment on in vivo insulin action. Peripheral insulin levels, hepatic glucose production (Ra), and overall glucose disposal (Rd) were studied in 6 awake, normal dogs given both 0.5 and 1.0 mU/kg per min pork insulin for 2.5 h. This produces stable hyperinsulinemia from 15 to 150 min. Fasting euglycemia was held constant by the glucose clamp technique and averaged 99% basal glucose in all studies. Ra and Rd were determined from infusion of [3-3H]glucose, begun 90 min prior to insulin infusion. 10 mg of the sulfonylurea, glipizide, was given daily to the test animals for the 10 to 20 d following appropriate control studies, then was withheld for 24 h, and the dogs were restudied. Glipizide treatment did not significantly alter basal glucose turnover, Ra, mean glucose values, or mean insulin levels as determined by radioimmunoassay. Increase in Rd above basal glucose turnover in response to insulin (ΔRd) was significantly (P <0.05) increased by glipizide treatment at both insulin dosage levels (paired analysis). At 1.0 mU/kg per min insulin, ΔRd rose from 2.6 mg/kg per min before glipizide to 6.5 mg/kg per min after glipizide treatment. At 0.5 mU/kg per min insulin, ΔRd went from 1.1 mg/kg per min before glipizide to 2.2 mg/kg per min after glipizide treatment. Glipizide treatment doubled the effects of insulin on Rd, while showing no significant effect upon insulin suppression of Ra. We conclude that a significant extrapancreatic chronic action of glipizide lies in its ability to selectively potentiate Rd.

AB - Investigative data have suggested that the extrapancreatic actions of the sulfonylureas may be paramount in their chronic antidiabetic action. The present study examines the effects of chronic sulfonylurea treatment on in vivo insulin action. Peripheral insulin levels, hepatic glucose production (Ra), and overall glucose disposal (Rd) were studied in 6 awake, normal dogs given both 0.5 and 1.0 mU/kg per min pork insulin for 2.5 h. This produces stable hyperinsulinemia from 15 to 150 min. Fasting euglycemia was held constant by the glucose clamp technique and averaged 99% basal glucose in all studies. Ra and Rd were determined from infusion of [3-3H]glucose, begun 90 min prior to insulin infusion. 10 mg of the sulfonylurea, glipizide, was given daily to the test animals for the 10 to 20 d following appropriate control studies, then was withheld for 24 h, and the dogs were restudied. Glipizide treatment did not significantly alter basal glucose turnover, Ra, mean glucose values, or mean insulin levels as determined by radioimmunoassay. Increase in Rd above basal glucose turnover in response to insulin (ΔRd) was significantly (P <0.05) increased by glipizide treatment at both insulin dosage levels (paired analysis). At 1.0 mU/kg per min insulin, ΔRd rose from 2.6 mg/kg per min before glipizide to 6.5 mg/kg per min after glipizide treatment. At 0.5 mU/kg per min insulin, ΔRd went from 1.1 mg/kg per min before glipizide to 2.2 mg/kg per min after glipizide treatment. Glipizide treatment doubled the effects of insulin on Rd, while showing no significant effect upon insulin suppression of Ra. We conclude that a significant extrapancreatic chronic action of glipizide lies in its ability to selectively potentiate Rd.

UR - http://www.scopus.com/inward/record.url?scp=0019422337&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019422337&partnerID=8YFLogxK

M3 - Article

C2 - 7009650

AN - SCOPUS:0019422337

VL - 67

SP - 1016

EP - 1023

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 4

ER -